AstraZeneca plans New York Stock Exchange listing but isn’t quitting London
PositiveU.S News

AstraZeneca, the second-largest company on the FTSE 100, is set to list its shares on the New York Stock Exchange while maintaining its presence in London and keeping its headquarters in Cambridge. This move highlights the company's growth ambitions and commitment to both markets, which is significant for investors and the pharmaceutical industry as it reflects confidence in AstraZeneca's future prospects.
— Curated by the World Pulse Now AI Editorial System